GGrantIndex
Sort

64,565 grants matching drug discovery

Emory-MSSM-GSK-NIMH Collaborative Mood and Anxiety Disorders Initiative

$2,059,619
Helen S Mayberg · Emory University · U19 · FY2011 · MH

Hormonal Control of Calcium Metabolism

$2,059,052
John T Potts · Massachusetts General Hospital · P01 · FY2020 · DK

Program for Resistance, Immunology, Surveillance & Modeling of Malaria in Uganda

$2,058,846
Matthew G Dorsey · University Of California, San Francisco · U19 · FY2015 · AI

DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs

$2,058,319
Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Program for Resistance, Immunology, Surveillance & Modeling of Malaria in Uganda

$2,058,047
Matthew G Dorsey · University Of California, San Francisco · U19 · FY2013 · AI

Hormonal Control of Calcium Metabolism

$2,057,397
John T Potts · Massachusetts General Hospital · P01 · FY2021 · DK

BPN14770 Safety and Cognitive Effect in Young and Elderly Subjects

$2,055,899
Mark E Gurney · Tetra Discovery Partners, Inc. · R44 · FY2016 · AG

SPORE in GI Cancer

$2,055,518
Robert J Coffey · Vanderbilt University · P50 · FY2015 · CA

EDGE CMT: Predicting bacteriophage susceptibility from Escherichia coli genotype

$2,055,157
Adam P Arkin · University Of California-Berkeley · · FY2022 · BIO

COBRE:Eukaryotic Pathogens Innovation Center (EPIC)

$2,054,534
Lesly A Temesvari · Clemson University · P20 · FY2019 · GM

Hormonal Control of Calcium Metabolism

$2,054,112
John T Potts · Massachusetts General Hospital · P01 · FY2022 · DK

Hormonal Control of Calcium Metabolism

$2,054,112
John T Potts · Massachusetts General Hospital · P01 · FY2023 · DK

Measuring, Modeling and Controlling Heterogeneity

$2,053,370
Joe W. Gray · Oregon Health & Science University · U54 · FY2020 · CA

FUNCTIONAL GENOMICS OF THE BETA-CELL

$2,052,934
University Of Pennsylvania · U01 · FY2005 · DK

Development of Novel Therapeutic Strategies in Human Leukemias

$2,052,164
Benjamin Levine Ebert · Dana-Farber Cancer Inst · P01 · FY2025 · CA

Molecular Analysis Of Leukocyte Activation By Chemoattractants

$2,051,146
Philip Murphy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI

Costimulatory Mechanisms of Autoimmunity (Composite)

$2,050,980
David A. Hafler · Yale University · P01 · FY2013 · AI

DEVELOPMENTAL BIOLOGY OF HUMAN ERYTHROPOIESIS

$2,049,193
Stuart H Orkin · Boston Children'S Hospital · P01 · FY2011 · HL

Comparative Oncology Program Laboratory

$2,049,125
Amy Leblanc · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

African American Cardiovascular pharmacogenetic CONsorTium (ACCOuNT): discovery and translation

$2,049,060
Minoli A Perera · Northwestern University At Chicago · U54 · FY2016 · MD

Molecular Targets COBRE

$2,048,959
Donald M Miller · University Of Louisville · P20 · FY2010 · RR

EFRI DCheM: Digital design of a network of distributed modular and agile manufacturing systems with optimal supply chain for personalized medical treatments

$2,048,275
Zoltan K Nagy · Purdue University · · FY2021 · ENG

VICKtOrY Early Clinical Trials Consortium

$2,044,455
Patricia M Lorusso · Yale University · UM1 · FY2023 · CA

Scientific Core - Compound Optimization and Prioritization.

$2,043,428
Anna Upton · Global Alliance For Tb Drug Development · U19 · FY2019 · AI

Basic and Translational Studies of Inborn Errors of Metabolism

$2,042,778
Forbes Porter · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2023 · HD